Skip to content

The Effect of Intraoperative Intravenous Lidocaine Infusion on Postoperative Pain and Recovery in Children (< 7 Years Old) Undergoing Thoracoscopic Surgery

The Effect of Intraoperative Intravenous Lidocaine Infusion on Postoperative Pain and Recovery in Children (< 7 Years Old) Undergoing Thoracoscopic Surgery:Prospective, Randomized Controlled Trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06710405
Enrollment
80
Registered
2024-11-29
Start date
2024-12-09
Completion date
2026-12-31
Last updated
2025-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Management After Surgery

Keywords

pediatric, thoracoscopic surgery, pain control, lidocaine

Brief summary

This study aims to investigate the efficacy of intraoperative intravenous lidocaine infusion on postoperative pain management and recovery in pediatric patients undergoing thoracoscopic pulmonary resection.

Interventions

DRUGLidocaine (drug)

a single bolus dose of lidocaine 1.5 mg/kg is administered concurrently with the induction of anesthesia, followed by a continuous infusion of lidocaine at a rate of 1.5 mg/kg/hr.

Continuous infusion of normal saline in the same volume as that administered to the lidocaine group.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Months to 7 Years
Healthy volunteers
No

Inclusion criteria

* Pediatric patients aged under 7 years undergoing thoracoscopic pulmonary resection

Exclusion criteria

* cardiac dysfunction requiring vasopressors or inotropic agents * atrioventricular block or bradycardia * Liver or kidney dysfunction * Hypersensitivity to local anesthetics

Design outcomes

Primary

MeasureTime frameDescription
FLACC (ace, Legs, Activity, Cry, Consolability scale) Scoreup to 1 hour after surgeryHighest FLACC Score recorded in the postanesthesia care unit (The scale is scored in a range of 0-10 with 0 representing no pain.)

Secondary

MeasureTime frameDescription
Remifentanil dosethroughout surgery (up to 3 hours)Total amount of remifentanil administered during surgery
ANI (Analgesia Nociception Index)throughout surgery (up to 3 hours)ANI (Analgesia Nociception Index) values during surgery (scale ranging from 0 (indicating maximum pain) to 100 (indicating no pain))
FLACC scores6 hours, 12 hours, and 24 hours postoperativelyFLACC scores at 6 hours, 12 hours, and 24 hours postoperatively
Total analgesic dosage administered postoperativelyup to 3 days after surgery
Postoperative complicationsuntil discharge (up to 3-4 days after surgery)

Countries

South Korea

Contacts

Primary ContactJi-Hyun Lee, MD, PhD
muslab6@snu.ac.kr82-2-2072-3661

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026